share_log
Benzinga ·  May 2 07:55
Sagimet Biosciences Shares Are Trading Higher After HC Wainwright & Co. Initiated Coverage on the Stock With a Buy Rating and Announced a $32 Price Target
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment